Atopic Dermatitis: Practical Recommendations for Step-Up Therapy
Current guidelines do not provide practical guidance for how to approach step-up therapy.
Data collection included socio-demographic variables, comorbidities, treatment-related clinical events, immunosuppressant usage, concomitant treatment, and adjustments in dose or type of immunosuppressant.
These findings indicate age-specific treatment approaches would likely benefit patients with atopic dermatitis.
After 16 weeks of treatment with dupilumab, the median SCORAD score decreased 55%.